Melissa A. Ashlock - Net Worth and Insider Trading

Melissa A. Ashlock Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Melissa A. Ashlock owns 1 companies in total, including aTyr Pharma Inc (LIFE) .

Click here to see the complete history of Melissa A. Ashlock’s form 4 insider trades.

Insider Ownership Summary of Melissa A. Ashlock

Ticker	Comapny	Transaction Date	Type of Owner
LIFE	aTyr Pharma Inc	2015-05-06	See Remarks

Melissa A. Ashlock Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Melissa A. Ashlock Ownership Network

Ownership Network List of Melissa A. Ashlock

No Data

Ownership Network Relation of Melissa A. Ashlock

Melissa A. Ashlock Owned Company Details

What does aTyr Pharma Inc do?

Who are the key executives at aTyr Pharma Inc?

Melissa A. Ashlock is the See Remarks of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , Chief Medical Officer Sanjay Shukla , and See Remarks Nancy Krueger .

aTyr Pharma Inc (LIFE) Insider Trades Summary

Over the past 18 months, Melissa A. Ashlock made no insider transaction in aTyr Pharma Inc (LIFE). Other recent insider transactions involving aTyr Pharma Inc (LIFE) include a net purchase of 55,000 shares made by Sanjay Shukla , a net sale of 3,156 shares made by Jill Marie Broadfoot , and a net purchase of 200,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 1,590 shares of aTyr Pharma Inc (LIFE) in total and bought 0 shares, with a net sale of 1,590 shares. During the past 18 months, 3,156 shares of aTyr Pharma Inc (LIFE) were sold and 255,000 shares were bought by its insiders, resulting in a net purchase of 251,844 shares.

aTyr Pharma Inc (LIFE)'s detailed insider trading history can be found in Insider Trading Tracker table.

aTyr Pharma Inc Insider Transactions

No Available Data

Melissa A. Ashlock Mailing Address

Above is the net worth, insider trading, and ownership report for Melissa A. Ashlock. You might contact Melissa A. Ashlock via mailing address: C/o Atyr Pharma, Inc., 3545 John Hopkins Court, Suite 250, San Diego Ca 92121.

Discussions on Melissa A. Ashlock

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.